이상반응 보고

VAERS ID	1626013
성별	여성
나이
주 코드	TX
제약회사	MODERNA
로트 번호
예방접종 횟수	1
접종일	2020-12-30
발병일	2020-12-31
상태

증상

• 피로(Fatigue)
• 발열(Pyrexia)
• 통증(Pain)
• 기침(Cough)
• 체온(Body temperature)

이환 중 질병

지병

Medical History/Concurrent Conditions: No adverse event (No reported medical history.)

기타 의료

이전 예방접종

알레르기

임상 검사

Test Date: 20210101; Test Name: Body temperature; Result Unstructured Data: 100.
4-100.
2 °F; Test Date: 20210101; Test Name: Body temperature; Result Unstructured Data: 100.
3 °F

증상 상세

aches; fatigue; fever of 100.
4-100.
2 range; cough; A spontaneous report was received from a female nurse concerning a female patient of unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) experienced cough, fever, aches and fatigue.
The patient's medical history was not provided.
No relevant concomitant medications were reported.
On 30 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 in the arm for prophylaxis of COVID-19 infection.
On 31 Dec 2020 the patient developed a cough.
On 1 Jan 2021, the patient developed a fever 100.
2-100.
4°F and on an unknown date patient experienced aches and fatigue.
Treatment for the event included paracetamol and ibuprofen.
Laboratory details included patient's body temperature which ranged between 100.
4 to 100.
2 degree Fahrenheit on 1-JAN-2021 and 100.
3 degree Fahrenheit.
Action taken with mRNA-1273 in response to the events was not reported.
The outcome of the events, developed a cough, fever, aches and fatigue, were unknown.
; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.